Background Banner

EIT Health

Catalyst Awardee

.lumen – Glasses for the Blind

Cornel Amariei, BSc; Gabriel Chindris, PhD; Mihai Ivascu, MA Competition Sponsor: EIT Health of the European Union “There are 40 million blind people today, increasing to over 100 million by 2050, and despite all technological advancements, when it comes to solutions for their mobility, there are only two options and…

Catalyst Awardee

Transcutaneous energy links for active medical implants, first application: mechanical circulatory support like Ventricular Assist Devices (VADs) and Total Artificial Hearts (TAHs)

Bengt Bern, MSc; Göran Dellgren, MD PhD; Kristján Jónsson, MD; Giovanni Maltese, MD PhD; Per Klockar, MSc; Stefan Winström, MSc Competition Sponsor: EIT Health of the European Union Patients die waiting in line for a heart transplant. Donor hearts are limited and there are only 6000 heart transplants made every…

Catalyst Awardee

Biel Digital Glasses

Jaume Puig, BA; Constanza Lucero, PhD; Eulalia Sanchez, MSc; Jordi Puig, BSc; Alex Cabañeros Lopez, MSc; Arthur Díaz Juan, MSc; Saskia Mülheim, MSc; Ishan Talathi, MBA Competition Sponsor: EIT Health of the European Union The name of the company came from Biel, the son of the founders, who was born…

Catalyst Awardee

Deviskan: democratizing melanoma early detection

Narcis Ricart Geli; Enric Campmol Ametller; Maria Sunyer i Rigau Competition Sponsor: EIT Health of the European Union Deviskan is a non-invasive medical device powered by Deep Learning and Artificial Intelligence able to take clinical and dermoscopic images to detect melanoma in early stages. In this context, Deviskan is able…

Catalyst Awardee

Antisense RNA treatment against myotonic dystrophy

Beatriz Llamusí, MsC, PhD; Ruben Artero, MsC, PhD; Pedro Fernández, MsC, PhD; Sheila Soriano, MsC; Marc Carrscosa Competition Sponsor: EIT Health of the European Union ARTHEx is developing an advanced RNA therapy for myotonic dystrophy type 1 (DM1) based on a portfolio of patent-protected antimiRs. These antimiRs act as long-acting…

Catalyst Awardee

New generation of contrast agents for MRI

Donatella Vecchione, PhD; Maria Russo, PhD; Alfonso Maria Ponsiglione, PhD; Enza Torino, PhD; Paolo Antonio Netti, PhD Competition Sponsor: EIT Health of the European Union Magnetic Resonance Imaging (MRI) is the most used diagnostic modality and more than 40% of MRI scans (> 30M/year) are performed with Contrast Agents (CAs).…


Catalyst Awardee

Resitu NoSurgery

Stefan Sowa, MSc, MBA; Heather Marshall-Heyman, MSc; Henrik Thunqvist, MSc; Therese Sundell, MSc Competition Sponsor: EIT Health of the European Union The aim is to develop a device that removes breast cancer tumors without open surgery. To determine if a lesion visible on X-ray is cancer a biopsy is necessary.…

Catalyst Awardee

Natural sperm selection for improved outcomes in IVF

Declan Keane, BSc, MBA; Sean Fair, PhD; Eoin White, PhD; David Newport, PhD; Leonard O’Sullivan, PhD; Barry Russell, BEng Competition Sponsor: EIT Health of the European Union One in six couples require fertility treatment and this is increasing due to increasing maternal age and a decrease in sperm counts by…

Catalyst Awardee

Salvus Health: Preventive Point-of-Care Platform

Philip Van den Bergh, BSc, MSc; Salvador Severich, BSc, MSc; Axel Vulsteke, BSc Competition Sponsor: EIT Health of the European Union Salvus Care 1.0 is a Point-of-Care solution that enables consumers/users take measurements at their community pharmacies, for the early detection of symptoms that can be associated with common chronic…

Sign up for updates